Drug manufacturer Eli Lilly plans to offer a half-priced version of its insulin medication Humalog, the company announced March 4.

Representatives from a handful of major global imaging societies are collaborating on a “living document” that will outline a clearer set of ethics for the use of AI in radiology.

The Blue Cross Blue Shield Association (BCBSA) published three proposals that would lower premiums by one-third for Obamacare insurance coverage and expand access to coverage for more than 4 million additional people.

CVS Health has named Roshan Navagamuwa as its new chief information officer to lead the company’s integration with Aetna, which it acquired late last year, The Wall Street Journal reported.

Zebra Medical Vision (Zebra-Med), an Israel-based deep learning imaging analytics company, announced it was granted CE certification for two of its AI-based products intended to speed up clinical review and diagnosis. One is for pneumothorax in chest x-rays and the other helps radiologists detect brain bleeds in CT scans.

The tension that has long simmered between providers and payers across U.S. healthcare is ripe for the easing. And the present moment may offer the best opportunity in decades for all parties to build trust where suspicion has become the default position. 

Health insurers selling their services through Healthcare.gov denied nearly one-fifth of claims in 2017. And only a tiny fraction of the affected consumers—less than one-half of one percent—appealed the decisions.

Nearly 30 million individuals of all ages in the U.S. were uninsured during the first nine months of 2018. This figure represents a little over 9 percent of the population, and it’s similar to the uncovered headcount from 2017. Still, it’s a notable improvement from 2010, when the Affordable Care Act was nascent and 19 million more people lacked coverage.